Literature DB >> 23801737

Progressive sleep and electroencephalogram changes in mice carrying the Huntington's disease mutation.

Sandor Kantor1, Lajos Szabo, Janos Varga, Marc Cuesta, A Jennifer Morton.   

Abstract

Sleep disturbances in Huntington's disease may be deleterious to the cognitive performance, affective behaviour, and general well-being of patients, but a comprehensive description of the progression of changes in sleep and electroencephalogram in Huntington's disease has never been conducted. Here we studied sleep and electroencephalogram disturbances in a transgenic mouse model of Huntington's disease (R6/2 mice). We implanted 10 R6/2 mice and five wild-type littermates with electromyography electrodes, frontofrontal and frontoparietal electroencephalogram electrodes and then recorded sleep/wake behaviour at presymptomatic, symptomatic and late stages of the disease. In addition to sleep-wake scoring, we performed a spectral analysis of the sleep electroencephalogram. We found that sleep and electroencephalogram were already significantly disrupted in R6/2 mice at 9 weeks of age (presymptomatic stage). By the time they were symptomatic, R6/2 mice were unable to maintain long periods of wakefulness and had an increased propensity for rapid eye movement sleep. In addition, the peak frequency of theta rhythm was shifted progressively from 7 Hz to 6 Hz during rapid eye movement sleep, whereas slow wave activity decreased gradually during non-rapid eye movement sleep. Finally, as the disease progressed, an abnormal electroencephalogram gamma activity (30-40 Hz) emerged in R6/2 mice irrespective of sleep states. This is reminiscent of the increased gamma power described in schizophrenic patients during sleep and events of psychosis. Gaining a better understanding of sleep and electroencephalogram changes in patients with Huntington's disease should be a priority, since it will enable clinicians to initiate appropriate investigations and to instigate treatments that could dramatically improve patients' quality of life.

Entities:  

Keywords:  EEG; R6/2 mice; REM sleep theta; gamma activity; slow wave activity

Mesh:

Substances:

Year:  2013        PMID: 23801737     DOI: 10.1093/brain/awt128

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  27 in total

Review 1.  'The clocks that time us'--circadian rhythms in neurodegenerative disorders.

Authors:  Aleksandar Videnovic; Alpar S Lazar; Roger A Barker; Sebastiaan Overeem
Journal:  Nat Rev Neurol       Date:  2014-11-11       Impact factor: 42.937

2.  Circadian dysfunction in the Q175 model of Huntington's disease: Network analysis.

Authors:  Benjamin Smarr; Tamara Cutler; Dawn H Loh; Takashi Kudo; Dika Kuljis; Lance Kriegsfeld; Cristina A Ghiani; Christopher S Colwell
Journal:  J Neurosci Res       Date:  2019-07-29       Impact factor: 4.164

3.  Hyperactivity and male-specific sleep deficits in the 16p11.2 deletion mouse model of autism.

Authors:  Christopher C Angelakos; Adam J Watson; W Timothy O'Brien; Kyle S Krainock; Thomas Nickl-Jockschat; Ted Abel
Journal:  Autism Res       Date:  2016-10-14       Impact factor: 5.216

4.  Lack of mutant huntingtin in cortical efferents improves behavioral inflexibility and corticostriatal dynamics in Huntington's disease mice.

Authors:  Ana María Estrada-Sánchez; Courtney L Blake; Scott J Barton; Andrew G Howe; George V Rebec
Journal:  J Neurophysiol       Date:  2019-11-06       Impact factor: 2.714

Review 5.  Choosing an animal model for the study of Huntington's disease.

Authors:  Mahmoud A Pouladi; A Jennifer Morton; Michael R Hayden
Journal:  Nat Rev Neurosci       Date:  2013-10       Impact factor: 34.870

Review 6.  Alteration of GABAergic neurotransmission in Huntington's disease.

Authors:  Maurice Garret; Zhuowei Du; Marine Chazalon; Yoon H Cho; Jérôme Baufreton
Journal:  CNS Neurosci Ther       Date:  2018-02-21       Impact factor: 5.243

7.  Relationship between subthalamic nucleus neuronal activity and electrocorticogram is altered in the R6/2 mouse model of Huntington's disease.

Authors:  Joshua W Callahan; Elizabeth D Abercrombie
Journal:  J Physiol       Date:  2015-06-25       Impact factor: 5.182

8.  Neurophysiological and Behavioral Effects of Anti-Orexinergic Treatments in a Mouse Model of Huntington's Disease.

Authors:  Magali Cabanas; Cristiana Pistono; Laura Puygrenier; Divyangana Rakesh; Yannick Jeantet; Maurice Garret; Yoon H Cho
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

9.  Early-onset sleep defects in Drosophila models of Huntington's disease reflect alterations of PKA/CREB signaling.

Authors:  Erin D Gonzales; Anne K Tanenhaus; Jiabin Zhang; Ryan P Chaffee; Jerry C P Yin
Journal:  Hum Mol Genet       Date:  2015-11-24       Impact factor: 6.150

10.  Quantitative Electroencephalographic Analysis Provides an Early-Stage Indicator of Disease Onset and Progression in the zQ175 Knock-In Mouse Model of Huntington's Disease.

Authors:  Simon P Fisher; Michael D Schwartz; Sarah Wurts-Black; Alexia M Thomas; Tsui-Ming Chen; Michael A Miller; Jeremiah B Palmerston; Thomas S Kilduff; Stephen R Morairty
Journal:  Sleep       Date:  2016-02-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.